Xtx Topco LTD Vor Biopharma Inc. Transaction History

Xtx Topco LTD

$2.23 Billion
Q2 2025

A detailed history of Xtx Topco LTD transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 40,943 shares of VOR stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,943

Holding current value

$1.43 Million

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$0.15 - $1.62 $6,141 - $66,327	40,943 New	40,943 $66,000
Q4 2024 Feb 13, 2025	BUY	$0.64 - $1.27 $45,944 - $91,170	71,788 New	71,788 $79,000
Q1 2024 May 13, 2024	BUY	$1.8 - $2.85 $33,561 - $53,138	18,645 New	18,645 $44,000

Others Institutions Holding VOR

# of Institutions

Shares Held

55.7M

Call Options Held

4.15M

Put Options Held

364K

Ra Capital Management, L.P. Boston, MA

39.6M
Shares

$1.38 Billion
1.4% of portfolio
5 Am Venture Management, LLC San Francisco, CA

6.36M
Shares

$222 Million
6.91% of portfolio
Vanguard Group Inc Valley Forge, PA

1.92M
Shares

$66.7 Million
0.0% of portfolio
Ubs Group Ag

1.53M
Shares

$53.3 Million
0.0% of portfolio
Johnson & Johnson New Brunswick, NJ

1.07M
Shares

$37.4 Million
0.59% of portfolio

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $1.33B
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account